“…Moreover, the list of clinical entities in which altered ADMA levels are found in the pediatric population continues to grow and includes conditions such as hypertension, hypercholesterolemia, chronic kidney disease or diabetes mellitus (see [ 17 ] for review). However, the information on dimethylarginines in the peri-/neonatal period is much scarce [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ]. Herein, we analyzed the plasma concentrations of ADMA, SDMA, l -arginine, and citrulline in a cohort of 130 VLBW preterm infants.…”